Related Experiment Video
Updated: Jul 2, 2026
07:32
Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane
Published on: March 16, 2015
Polyethylenimine-mediated cochlear gene transfer in guinea pigs
Brian Tiong Gee Tan1, Kok Heng Foong, Myranda Mui Gek Lee
1Delivery of Drugs, Proteins, and Genes Group, Institute of Bioengineering and Nanotechnology, Singapore, Singapore.
Archives of Otolaryngology--Head & Neck Surgery
|August 20, 2008
Summary
Sustained delivery of polyethylenimine (PEI) improved gene transfer in the cochlea, offering a nonviral alternative for gene therapy. This method maintained tissue integrity without inflammation, showing promise for future applications.
Area of Science:
- Otic gene therapy
- Nonviral gene delivery systems
Background:
- Cochlear gene therapy holds promise for treating hearing loss.
- Nonviral vectors like polyethylenimine (PEI) are being explored as safer alternatives to viral vectors.
Purpose of the Study:
- To compare polycationic-mediated cochlear gene transfer using linear PEI via cochleostomy versus osmotic pump infusion.
- To evaluate the efficacy and safety of PEI-based gene delivery in the guinea pig cochlea.
Main Methods:
- An optimized PEI/DNA complex ratio was determined using dissociated cochlear cultures.
- PEI-enhanced green fluorescent protein reporter gene DNA was delivered via single inoculation (cochleostomy) or sustained release (osmotic pump) into guinea pig cochleas.
Main Results:
- Sustained release of PEI vector significantly improved transfection efficiency compared to single inoculation.
- PEI delivery maintained cochlear tissue architecture and showed no signs of inflammation.
- Transfection was primarily observed in the perilymphatic space, indicating a need for targeted delivery to the scala media for organ of Corti transfection.
Conclusions:
- Linear PEI can effectively transfect the cochlea in vivo when delivered via sustained infusion.
- Sustained delivery of PEI represents a viable nonviral strategy for cochlear gene therapy.
- Further optimization is needed to target gene delivery to specific cochlear structures like the organ of Corti.
